
Mettler-Toledo International MTD
$ 1 324.63
-0.03%
Annual report 2025
added 02-06-2026
Mettler-Toledo International Total Non Current Liabilities 2011-2026 | MTD
Annual Total Non Current Liabilities Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 1.61 B | 1.29 B | 1.31 B | 1.14 B | 843 M | 611 M | 654 M | 728 M | 812 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.61 B | 611 M | 1 B |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 16.2 | 2.24 % | $ 168 M | ||
|
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
3.29 B | $ 115.31 | 0.22 % | $ 35.1 B | ||
|
BioNano Genomics
BNGO
|
16.4 M | $ 1.13 | - | $ 6.15 M | ||
|
Interpace Biosciences
IDXG
|
10 M | $ 2.25 | -2.17 % | $ 9.95 M | ||
|
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
17.9 M | $ 16.27 | 1.37 % | $ 867 M | ||
|
Medpace Holdings
MEDP
|
73.8 M | $ 500.74 | 1.46 % | $ 14.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M | ||
|
Myriad Genetics
MYGN
|
107 M | $ 4.44 | 2.07 % | $ 411 M | ||
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
435 M | $ 7.92 | 2.99 % | $ 1.01 B | ||
|
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
574 K | $ 1.39 | 1.46 % | $ 1.85 M | ||
|
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
2.76 M | $ 23.13 | - | $ 642 M | ||
|
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | ||
|
Senseonics Holdings
SENS
|
163 M | $ 6.66 | -0.3 % | $ 278 M | ||
|
Charles River Laboratories International
CRL
|
2.35 B | $ 175.83 | 0.1 % | $ 8.71 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | ||
|
Soleno Therapeutics
SLNO
|
10.8 M | $ 52.54 | -0.17 % | $ 2.67 B | ||
|
Danaher Corporation
DHR
|
26.9 B | $ 191.02 | 0.74 % | $ 136 B | ||
|
Neuronetics
STIM
|
24.6 M | $ 1.35 | - | $ 89 M | ||
|
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
2.04 B | $ 123.13 | 1.82 % | $ 19.6 B | ||
|
Fulgent Genetics
FLGT
|
2.26 M | $ 14.96 | 3.67 % | $ 452 M | ||
|
Thermo Fisher Scientific
TMO
|
22.5 B | $ 501.62 | 1.11 % | $ 189 B | ||
|
Trinity Biotech plc
TRIB
|
106 M | $ 0.68 | -4.69 % | $ 61.9 M | ||
|
Guardant Health
GH
|
91.4 M | $ 79.09 | 0.62 % | $ 9.92 B | ||
|
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
4.56 M | $ 49.04 | 2.36 % | $ 2.93 B | ||
|
Anixa Biosciences
ANIX
|
4.17 M | $ 2.74 | 1.86 % | $ 88.9 K | ||
|
Biomerica
BMRA
|
1.57 M | $ 2.07 | -2.73 % | $ 4.75 M | ||
|
Invitae Corporation
NVTA
|
320 M | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
8.08 B | $ 28.28 | -0.11 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
461 M | $ 108.74 | 1.53 % | $ 8.97 B | ||
|
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 261.85 | 0.35 % | $ 21.8 B | ||
|
Natera
NTRA
|
124 M | $ 201.35 | 4.31 % | $ 19.8 B | ||
|
Celcuity
CELC
|
69.2 K | $ 120.37 | 2.75 % | $ 5.63 B | ||
|
Lantheus Holdings
LNTH
|
225 M | $ 81.02 | 0.53 % | $ 5.47 B | ||
|
Waters Corporation
WAT
|
1.28 B | $ 318.49 | -0.47 % | $ 19 B |